Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-21-006927
Filing Date
2021-03-26
Accepted
2021-03-26 16:42:34
Documents
3
Period of Report
2021-03-26

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 566922
2 proxy_01.jpg GRAPHIC 185358
3 proxy_02.jpg GRAPHIC 154331
  Complete submission text file 0001493152-21-006927.txt   1036033
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37348 | Film No.: 21778047
SIC: 2834 Pharmaceutical Preparations